Language
English
Publication Date
7-1-2025
Journal
JACC: Basic to Translational Science
DOI
10.1016/j.jacbts.2025.02.004
PMID
40243956
PMCID
PMC12434206
PubMedCentral® Posted Date
4-16-2025
PubMedCentral® Full Text Version
Post-print
Abstract
Atrial fibrillation (AF) often coexists with heart failure, both involving inflammatory signaling and cardiac fibroblasts. To understand the role of fibroblast NLR family pyrin domain containing 3 (NLRP3) inflammasome in cardiac function, we found that NLRP3 was up-regulated in atrial fibroblasts from AF patients. Fibroblast-specific activation of NLRP3 in mice induced AF-promoting atrial myopathy and heart failure with diastolic dysfunction, accompanied by increased fibrosis, and reduced conduction velocity. Knockdown of NLRP3 prevented the AF-promoting atrial substrate and cardiomyopathy in the context of NLRP3 activation in fibroblasts. We identify the fibroblast NLRP3 inflammasome as a key pathway governing the promotion of proarrhythmic fibrosis in AF and cardiomyopathy.
Keywords
atrial cardiomyopathy, atrial fibrillation, cardiac fibroblast, fibrosis, inflammasome
Published Open-Access
yes
Recommended Citation
Li, Luge; Coarfa, Cristian; Yuan, Yue; et al., "Fibroblast-Restricted Inflammasome Activation Promotes Atrial Fibrillation and Heart Failure With Diastolic Dysfunction" (2025). Faculty and Staff Publications. 4236.
https://digitalcommons.library.tmc.edu/baylor_docs/4236
Graphical Abstract